Related Experiment Video
Updated: Sep 20, 2025

T and B Cell Receptor Immune Repertoire Analysis using Next-generation Sequencing
Published on: January 12, 2021
TRUST4 Interrogates the Immune Receptor Repertoire in Oncology and Immunotherapy
1Center for Epigenetics and Disease Prevention, Institute of Biosciences and Technology, Texas A&M Health, Texas A&M University, Houston, Texas.
Abstract:
The immune receptor repertoire is a set of cellular receptors responsible for recognizing foreign antigens. Characterizing the immune receptor repertoire is critical to understanding mechanisms of human adaptive immunity and developing new approaches to cancer immunotherapy. In this issue, Song and colleagues utilize an advanced bioinformatics pipeline on large-scale samples to investigate the diversity of receptor repertoires in tumors and identify factors correlated with favorable outcomes. The result highlights the role of B cells in immunotherapy responses and suggests establishing B cells as biomarkers in future research. See related article by Song et al., p. 788 (3).
Insights
Characterizing the immune receptor repertoire is key for understanding immunity and cancer immunotherapy. Research shows B cells play a role in immunotherapy responses, suggesting their potential as biomarkers.
Area of Science:
- Immunology
- Bioinformatics
- Cancer Research
Background:
- The immune receptor repertoire, comprising cellular receptors recognizing foreign antigens, is crucial for adaptive immunity.
- Understanding repertoire diversity aids in developing novel cancer immunotherapies.
- Advanced bioinformatics and large-scale sample analysis are essential for repertoire characterization.
Discussion:
- Song and colleagues employed a sophisticated bioinformatics pipeline to analyze tumor receptor repertoires.
- The study investigated the diversity of these repertoires across large sample sets.
- Factors correlating with favorable patient outcomes were identified.
Key Insights:
- The research highlights the significant role of B cells in the efficacy of immunotherapy treatments.
- Specific B cell characteristics are associated with positive responses to cancer immunotherapy.
- This underscores the importance of B cells beyond traditional immune cell roles.
Outlook:
- B cells show promise as potential biomarkers for predicting immunotherapy success.
- Future research should focus on establishing and validating B cells as reliable biomarkers.
- This could lead to more personalized and effective cancer treatment strategies.
Related Concept Videos
Tumor Immunotherapy
Cytotoxic T Cells-mediated Immune Response
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Diversity of Antigen Receptors
Before encountering any antigen, lymphocytes express these receptors. On B cells, the antigen receptor is a membrane-bound antibody molecule called BCR; on T cells, it is a T cell receptor or TCR. B and T cell receptors are composed of two...
T Cell Activation and Clonal Selection
Naive T cells that have not yet encountered an antigen express two primary CD...
Cells of the Adaptive Immune Response
Immune Surveillance by NK Cells and Phagocytes
Natural Killer Cells: The Fast Responders
NK cells are large granular lymphocytes found in the blood and lymphatic system. These...

